dexmedetomidine has been researched along with mannitol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brost, BC; Handlogten, KS; Parney, IF; Pasternak, JJ; Sharpe, EE | 1 |
| Hu, Z; Huang, Y; Li, F; Zhan, H | 1 |
1 review(s) available for dexmedetomidine and mannitol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for dexmedetomidine and mannitol
| Article | Year |
|---|---|
Dexmedetomidine and Mannitol for Awake Craniotomy in a Pregnant Patient.
Topics: Administration, Intravenous; Adult; Astrocytoma; Brain Mapping; Brain Neoplasms; Craniotomy; Dexmedetomidine; Female; Gestational Age; Humans; Hypnotics and Sedatives; Magnetic Resonance Imaging; Mannitol; Monitoring, Intraoperative; Motor Activity; Organ Size; Pregnancy; Pregnancy Complications, Neoplastic; Speech; Temporal Lobe; Time Factors; Treatment Outcome; Uterus; Wakefulness | 2015 |
Dexmedetomidine ameliorates diabetic cardiomyopathy by inhibiting ferroptosis through the Nrf2/GPX4 pathway.
Topics: bcl-2-Associated X Protein; Dexmedetomidine; Diabetes Mellitus; Diabetic Cardiomyopathies; Ferroptosis; Humans; Mannitol; NF-E2-Related Factor 2; Reactive Oxygen Species; Superoxide Dismutase | 2023 |